A Multiple‐Ascending‐Dose Study to Evaluate Safety, Pharmacokinetics, and Pharmacodynamics of a Novel GPR40 Agonist, TAK‐875, in Subjects With Type 2 Diabetes

By  

CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol. 92, Iss. 1, 2012-07 ,pp. : 29-39

John Wiley & Sons Inc

Access to resources Recommend Favorite

Dose-escalation study of the pharmacokinetics and pharmacodynamics of rivaroxaban in healthy elderly subjects

By Kubitza Dagmar   Becka Michael   Roth Angelika   Mueck Wolfgang  

Current Medical Research and Opinion, Vol. 24, Iss. 10, 2008-10 ,pp. : 2757-2765

Informa Healthcare

Access to resources Recommend Favorite

Phase 1, open‐label, dose escalation, safety, and pharmacokinetics study of ME‐344 as a single agent in patients with refractory solid tumors

By  

CANCER, Vol. 121, Iss. 7, 2015-04 ,pp. : 1056-1063

John Wiley & Sons Inc

Access to resources Recommend Favorite

Blinatumomab Pharmacodynamics and Exposure–Response Relationships in Relapsed/Refractory Acute Lymphoblastic Leukemia

By  

JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 58, Iss. 2, 2018-02 ,pp. : 168-179

John Wiley & Sons Inc

Access to resources Recommend Favorite

Effect of aliskiren, an oral direct renin inhibitor, on the pharmacokinetics and pharmacodynamics of a single dose of acenocoumarol in healthy volunteers

By Huang H.-L. A.   Vaidyanathan S.   Yeh C.-M.   Bizot M.-N.   Dieterich H. A.   Dole W. P.   Howard D.  

Current Medical Research and Opinion, Vol. 24, Iss. 9, 2008-09 ,pp. : 2449-2456

Informa Healthcare

Access to resources Recommend Favorite